The 22 nd Annual Cleveland Review of Rheumatic Diseases

Transcription

1 The MetroHealth System Division of Rheumatology and Cleveland Society of Rheumatology presents The 22 nd Annual Cleveland Review of Rheumatic Diseases A comprehensive review of the advances in research and treatment for autoimmune and inflammatory disease states Friday, May 11 & Saturday, May 12, 2012 The Wyndham Hotel Cleveland Playhouse Square, Cleveland, Ohio Register Today!

2 Agenda Friday, May 11, :00-7:45 am Registration / Continental Breakfast 7:45-8:00 am Welcome, Introduction, Announcements 8:00-8:45 am Autoimmune Disease Pathogenesis from Bench to Bedside: Epigenetics Bruce C. Richardson, MD, PhD 8:45-9:30 am Current and Emerging Therapies of Lupus Nephritis Stanley Ballou, MD 9:30-10:15 am Update of the Treatment of Inflammatory Myopathy Chester V. Oddis, MD 10:15-10:30 am Break Exhibits 10:30-11:15 am Connective Tissue Disease-Associated Interstitial Lung Disease Aryeh Fischer, MD 11:15 am - 12:00 pm Is Anti-B-Cell Therapy the First Line for Treating Systemic Vasculitis? Carol Langford, MD, MHS 12:00-1:00 pm Lunch Panel Discussion 1:00-1:45 pm Rheumatoid Arthritis: Pathogenesis to New Therapies Richard Pope, MD 1:45-2:30 pm Arthritis Gene Therapy an Update Chris Evans, PhD 2:30-3:15 pm Spondyloarthritis Update 2012 Muhammad Asim Khan, MD 3:15-3:25 pm Panel Discussion 3:25-3:40 pm Break Exhibits 3:40-4:20 pm Treating Rheumatoid Arthritis in the Age of Hepatitis C; Mechanisms of Action of Newly Available Antiviral Therapy and How Treatment of RA Patients with Hepatitis C Should be Adapted Donald D. Anthony, MD, PhD 4:20-5:05 pm What Adult Rheumatologists Should Know About Treating Arthritis in Children and Adolescents Nora G. Singer, MD 5:05-5:15 pm Panel Discussion 5:15 pm Attendee Reception Exhibits Cover: A graphic depiction of a microarray of the gene expression pattern in human cartilage cells. Photo courtesy of Tariq M. Haqqi, PhD, MetroHealth Division of Rheumatology.

3 Saturday, May 12, :00-8:00 am Registration / Continental Breakfast 8:00-8:45 am New and Emerging Therapeutic Strategies in Osteoporosis Marina Magrey, MD 8:45-9:30 am Current Controversies in the Treatment of Osteoporosis Kenneth G. Saag, MD, MSc 9:30-10:15 am Therapeutic Targeting of Bone Disease Steve R. Goldring, MD Panel Discussion 10:15-10:30 am Break Exhibits 10:30-11:15 am Update on Psoriatic Arthritis: Perspectives from a Dermatology-Rheumatology Experience Elaine Husni, MD, MPH 11:15 am - 12:00 pm Pathophysiology of OA: Therapeutic Implications Steve R. Goldring, MD Panel Discussion & Program Evaluation overview This annual conference provides a comprehensive, state-of-the-art review of the latest advances in the diagnosis and management of rheumatic diseases. Objectives At the conclusion of these activities attendees should be able to: 1. Describe the role of pro-inflammatory cytokines in the pathogenesis of rheumatoid and related inflammatory arthritis. 2. Contrast and compare the potential benefits and risks of small molecule inhibitors for arthritis with newly available and established biological therapies. 3. Describe the mechanisms of actions and current and potential future utility of existing and novel therapies for systemic lupus erythematosus and related connective tissue disease. 4. Discuss how to recognize spondyloarthritis, explain treatment approaches, and describe the effects of nonbiological and biological DMARDs. 5. List potential pitfalls evaluating and treating osteoporosis in patients with underlying rheumatic disease. 6. Explain the risks and benefits of established and novel therapies to treat primary osteoporosis, describe an algorithm for initiating therapy, and monitoring its efficacy and describe conditions under which therapy should be altered or terminated. Target audience This comprehensive review is directed to rheumatologists, primary care physicians, pain management specialists and other interested physicians, nurses and allied health care professionals.

4 faculty Activity Director Muhammad Asim Khan, MD Professor of Medicine, Case Western Reserve University MetroHealth Medical Center MetroHealth Division of Rheumatology Stanley Ballou, MD Associate Professor of Medicine, Case Western Reserve University Nora G. Singer, MD Professor of Medicine and Pediatrics, Case Western Reserve University Director, Division of Rheumatology, MetroHealth Medical Center Marina Magrey, MD Assistant Professor, Case Western Reserve University Director, Osteoporosis and Metabolic Bone Clinic, MetroHealth Medical Center Conference Planning Committee Muhammad Asim Khan, MD, Chair Nora G. Singer, MD Stanley Ballou, MD Cheung Yue, MD Marina Magrey, MD Sobia Hassan, MD Tariq Haqqi, PhD James Armstrong Carmen Feliciano Bradley Galvan Kim Montgomery Kathy Plummer Holly Bennett Guest Faculty Donald D. Anthony, MD, PhD Associate Professor of Medicine and Pathology, Divisions of Rheumatic Disease and Infectious Disease, Cleveland VA Medical Center and University Hospitals of Cleveland Case Western Reserve University Chris Evans, PhD Maurice Müller Professor of Orthopaedic Surgery, Harvard Medical School Aryeh Fischer, MD Associate Professor of Medicine, Division of Rheumatology, Interstitial Lung Disease Program, National Jewish Health Director, Scleroderma Clinic, University of Colorado Steve R. Goldring, MD Chief Scientific Officer, Richard L. Menschel Research Chair, Hospital for Specialty Surgery Professor of Medicine, New York Presbyterian Healthcare System and Weill Cornell Medical College Elaine Husni, MD, MPH Department Vice Chair, Arthritis Center Director Clinical Outcomes Research, Orthopedic and Rheumatologic Institute, Cleveland Clinic Carol Langford, MD, MHS Harold C. Schott Chair in Rheumatic and Immunologic Diseases Director, Center for Vasculitis Care and Research, Cleveland Clinic Chester V. Oddis, MD Professor of Medicine, University of Pittsburgh School of Medicine, Division of Rheumatology and Clinical Immunology Richard Pope, MD Mabel Greene Myers Professor of Medicine Rheumatology Division Chief, Department of Medicine, Northwestern University Bruce C. Richardson, MD, PhD Professor of Medicine, University of Michigan Chief, Section of Rheumatology, Ann Arbor VA Medical Center Kenneth G. Saag, MD, MSc Jane Knight Lowe Professor of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham

5 general information Location Wyndham Cleveland Hotel at Playhouse Square 1260 Euclid Avenue, Cleveland, OH Phone: Hotel Accommodations A block of rooms has been reserved at the Wyndham Cleveland Hotel at Playhouse Square. For further information about this meeting, contact: Carmen Feliciano Phone: Fax: cfeliciano@metrohealth.org or visit rheumatic. To make your reservation, contact the Hotel Reservations Department at Please identify yourself as being with the Cleveland Review of Rheumatic Diseases Conference. RATE: $ per night. Ground Transportation Taxi service is available from Cleveland Hopkins International Airport to the Wyndham Cleveland Hotel at Playhouse Square. Registration and Cancellation Preregistrations are accepted by fax or online until 4:00 pm ET May 3, To register after this date, you must do so on-site. In case of cancellation, a full refund will be made if cancelled by April 21, After April 21, 2011, a $100 cancellation fee will be deducted from your refund. Written notification of your cancellation is required to process your refund. NO REFUNDS WILL BE ISSUED AFTER MAY 7, Parking Valet Parking is available on-site at the Wyndham Cleveland Hotel at Playhouse Square. Self-parking is available at several parking garages within a short walk. DIRECTIONS TO HOTEL From Cleveland Hopkins Airport Highway 71 North to East Ninth St. exit. Take East Ninth St. to Euclid Ave. and turn right. The Hotel is on the right hand side. From Akron/Canton Highway 77 North to East Ninth St. exit. Take East Ninth St. to Euclid Ave. and turn right. The Hotel is on the right hand side. From Toledo/Detroit Highway 90 East to Downtown Cleveland. Exit East Ninth St. Take East Ninth St. to Euclid Ave. and turn right. The Hotel is on the right hand side. From Youngstown/Pittsburgh Highway 76 to the Ohio Turnpike (I-80). Follow I-80 to Exit 10 (I-71) North to the East Ninth St. exit. Take East Ninth St. to Euclid Ave. and turn right. The Hotel is on the right hand side. From Columbus/Cincinnati I-71 North to East Ninth St. exit. Take East Ninth St. to Euclid Ave. and turn right. The Hotel is on the right hand side. Playhouse Square

6 The MetroHealth System Division of Rheumatology and Cleveland Society of Rheumatology 22 nd Annual Cleveland Review of Rheumatic Diseases: A comprehensive review of the advances in research and treatment for autoimmune and inflammatory disease states May 11 & 12, The MetroHealth System Division of Rheumatology 2500 MetroHealth Drive Cleveland, Ohio PrsrT std us Postage PAID Cleveland, oh Permit No. 633

7 registration form Register online and pay with credit card at Name Address City State Zip Code Title / Hospital Affiliation Specialty Phone Fax Please Check One: CNM CNP DO MD RN Other Registration Fee: see reverse side Method of Payment: Check MasterCard VISA Discover (Please make check payable to MetroHealth Foundation) Amount $ Credit Card Holder s Name (as it appears on credit card) Card Number Exp. Date Signature

8 REGISTRATION FEE Early Bird Before After After March 1, 2012 March 1 May 1, 2012 Physician $225 $300 $350 Resident/Fellow free free free Nurse $125 $150 $200 Allied Health Professional $125 $150 $200 Other Corporate $325 $400 $450 REGISTER ONLINE at Once you register online, please do not mail or fax in a registration form. or REGISTER BY FAX to or REGISTER BY MAIL to Carmen Feliciano, MetroHealth Medical Center, Division of Rheumatology, 2500 MetroHealth Dr., Cleveland, OH Accreditation Physician The MetroHealth System is accredited by the Ohio State Medical Association to provide continuing medical education for physicians. The MetroHealth System designates this educational activity for a maximum of 11.0 AMA PRA Category 1 Credit(s). TM Physicians should only claim credit commensurate with the extent of their participation in the activity. Nurse The MetroHealth System (OH-087/050112) is an approved provider of continuing education by the Ohio Nurses Association (OBN ), an accredited approver by the American Nurses Credentialing Center s Commission on Accreditation. Faculty Disclosure The MetroHealth System has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest. Faculty declaring a relevant commercial interest will be identified in the activity syllabus. Americans with Disabilities Act The MetroHealth System fully intends to comply with the legal requirements of the Americans with Disabilities Act. If you need assistance, please notify us at least two weeks prior to the activity.